The Latest in Myelodysplastic Syndrome

Amgen withdraws application for darbepoetin alfa

March 24, 2018

Manufactured graft deemed safe in blood cancer patients

March 21, 2018

HSCT approach provides ‘excellent’ survival in FA

March 2, 2018

Expanded UCB product can stand alone

February 27, 2018

NK-cell therapy in resistant MDS, AML

February 16, 2018

Azacitidine now available in China

February 9, 2018

Predicting response to AZA in MDS, CMML

January 21, 2018

FDA grants drug orphan designation for AML, MDS

November 30, 2017

Rigosertib produces better OS in MDS than tAML

November 16, 2017

Generic azacitidine approved in Canada

November 16, 2017

Drug receives fast track designation for lower-risk MDS

November 2, 2017

ATLG fights GVHD but reduces PFS, OS

October 26, 2017

Drug receives orphan designation for treatment of MDS

October 8, 2017

Mutations impact outcomes in AML, MDS

September 27, 2017

FDA grants RMAT designation to HSCT adjunct

September 21, 2017